Successful Incorporation of Exosome-Capturing Antibody-siRNA Complexes into Multiple Myeloma Cells and Suppression of Targeted mRNA Transcripts
Nucleic acid medicines have been developed as new therapeutic agents against various diseases; however, targeted delivery of these reagents into cancer cells, particularly hematologic cancer cells, via systemic administration is limited by the lack of efficient and cell-specific delivery systems. We...
Main Authors: | Emi Soma, Asako Yamayoshi, Yuki Toda, Yuji Mishima, Shigekuni Hosogi, Eishi Ashihara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/566 |
Similar Items
-
Development of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA
by: Asako Yamayoshi, et al.
Published: (2020-06-01) -
Long-term stability and scale-up of noncovalently bound gold nanoparticle-siRNA suspensions
by: Anna V. Epanchintseva, et al.
Published: (2019-12-01) -
Chitosan Oleate Coated PLGA Nanoparticles as siRNA Drug Delivery System
by: Dalila Miele, et al.
Published: (2021-10-01) -
Target mRNA abundance dilutes microRNA and siRNA activity
by: Aaron Arvey, et al.
Published: (2010-01-01) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012-01-01)